Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume -, Issue -, Pages annrheumdis-2020-218296
Publisher
BMJ
Online
2020-08-13
DOI
10.1136/annrheumdis-2020-218296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain
- (2020) Mario Fernández‐Ruiz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical outcome in solid organ transplant recipients with COVID‐19: A single‐center experience
- (2020) Giovanna Travi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Current pharmacological treatments for COVID‐19: What's next?
- (2020) Cristina Scavone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
- (2020) Matthew J Cummings et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
- (2020) Wenhua Liang et al. JAMA Internal Medicine
- American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic
- (2020) Ted R. Mikuls et al. Arthritis & Rheumatology
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
- (2018) Tamas Fulop et al. Frontiers in Immunology
- Host and Environmental Factors Influencing Individual Human Cytokine Responses
- (2016) Rob ter Horst et al. CELL
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Jasvinder A Singh et al. LANCET
- Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
- (2008) Prodromos I Sidiropoulos et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started